Trovan Preservative Free is a drug owned by Pfizer Chemicals Div Pfizer Inc. It is protected by 3 US drug patents filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Jul 23, 2018. Details of Trovan Preservative Free's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US6194429 | Alatrofloxacin parenteral compositions |
Jul, 2018
(6 years ago) |
Expired
|
| US6080756 | Polymorphs of the prodrug 6-N-(L-ALA-L-ALA)-trovafloxacin |
Jul, 2016
(8 years ago) |
Expired
|
| US5763454 | Crystal form of anhydrous 7-( 1α,5α,6α!-6-amino-3-azabicyclo 3.1.0!hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8 naphthyridine-3-carboxylic acid, methanessulfonic acid salt |
Jun, 2015
(9 years ago) |
Expired
|
US patents provide insights into the exclusivity only within the United States, but Trovan Preservative Free is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Trovan Preservative Free's family patents as well as insights into ongoing legal events on those patents.
Trovan Preservative Free's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Trovan Preservative Free's generic launch date based on the expiry of its last outstanding patent is estimated to be Jul 23, 2018 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Trovan Preservative Free Generics:
There are no approved generic versions for Trovan Preservative Free as of now.
Alternative Brands for Trovan Preservative Free
Trovan Preservative Free which is used for treating bacterial infections., has several other brand drugs in the same treatment category . Given below is the list of those companies and their brand drugs, to help you identify new opportunities, assess competitors, and plan your market strategies more effectively.
| Drug Owner | Drug Name | Treatment Area | ||||
|---|---|---|---|---|---|---|
| Abbvie |
| |||||
| Baxter Hlthcare Corp |
| |||||
| Cubist Pharms Llc |
| |||||
| Cumberland |
| |||||
| Lg Chem Ltd |
| |||||
| Pfizer |
| |||||
| Pf Prism Cv |
| |||||
| Rempex |
| |||||
| Shionogi Inc |
| |||||
| Wyeth Pharms |
| |||||
| Xellia Pharms Aps |
| |||||
About Trovan Preservative Free
Trovan Preservative Free is a drug owned by Pfizer Chemicals Div Pfizer Inc. It is used for treating bacterial infections. Trovan Preservative Free uses Alatrofloxacin Mesylate as an active ingredient. Trovan Preservative Free was launched by Pfizer in 1997.
Approval Date:
Trovan Preservative Free was approved by FDA for market use on 18 December, 1997.
Active Ingredient:
Trovan Preservative Free uses Alatrofloxacin Mesylate as the active ingredient. Check out other Drugs and Companies using Alatrofloxacin Mesylate ingredient
Treatment:
Trovan Preservative Free is used for treating bacterial infections.
Dosage:
Trovan Preservative Free is available in injectable form for injection use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| EQ 300MG BASE/VIAL | INJECTABLE | Discontinued | INJECTION |
| EQ 200MG BASE/VIAL | INJECTABLE | Discontinued | INJECTION |